China

News
Photo: Bayer AG

Bayer grabs Chinese okay for CKD therapy Kerendia

On the heels of approvals in the US, Europe and Japan, Bayer's Kerendia for chronic kidney disease (CKD) associated with type 2 diabetes has been cleared for use in China, unlocking another

Market Access
pharmaceutical supply chain

US frets over pharma supply chain security

The pandemic highlighted how fragile the global manufacturing network is, as supply of certain products was limited and regulatory inspections became difficult to carry out.